Genmab A/S (CPH:GMAB)
Denmark
· Delayed Price · Currency is DKK 1,458.50
+21.00 (1.46%)
Aug 14, 2025, 4:59 PM CET
Genmab Market Cap
Genmab has a market cap or net worth of 89.71 billion as of August 14, 2025. Its market cap has decreased by -27.25% in one year.
Market Cap
89.71B
Enterprise Value
72.23B
Revenue
23.16B
Ranking
n/a
PE Ratio
10.62
Stock Price
1,458.50
Market Cap Chart
Since October 18, 2000, Genmab's market cap has increased from 3.68B to 89.71B, an increase of 2,334.94%. That is a compound annual growth rate of 13.72%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 1,433.45B |
| Coloplast | 135.96B |
| Demant | 53.94B |
| ALK-Abelló | 39.17B |
| H. Lundbeck | 33.55B |
| Ambu A/S | 24.23B |
| Zealand Pharma | 23.43B |
| Bavarian Nordic | 18.46B |